142 related articles for article (PubMed ID: 34913949)
1. Association of Antiparietal Cell and Anti-Intrinsic Factor Antibodies With Risk of Gastric Cancer.
Song M; Camargo MC; Katki HA; Weinstein SJ; Männistö S; Albanes D; Surcel HM; Rabkin CS
JAMA Oncol; 2022 Feb; 8(2):268-274. PubMed ID: 34913949
[TBL] [Abstract][Full Text] [Related]
2. Serologic Profile of Antiparietal Cell Antibodies, Pepsinogens, and
Wang SM; Roth MJ; Murphy GA; Dawsey SM; Fan JH; Taylor PR; Qiao YL; Abnet CC
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2022-2029. PubMed ID: 31501152
[TBL] [Abstract][Full Text] [Related]
3. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
[TBL] [Abstract][Full Text] [Related]
4. No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese.
Hishida A; Matsuo K; Goto Y; Mitsuda Y; Hiraki A; Naito M; Wakai K; Tajima K; Hamajima N
Gastric Cancer; 2010 Mar; 13(1):43-9. PubMed ID: 20373075
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study.
Huang J; Zagai U; Hallmans G; Nyrén O; Engstrand L; Stolzenberg-Solomon R; Duell EJ; Overvad K; Katzke VA; Kaaks R; Jenab M; Park JY; Murillo R; Trichopoulou A; Lagiou P; Bamia C; Bradbury KE; Riboli E; Aune D; Tsilidis KK; Capellá G; Agudo A; Krogh V; Palli D; Panico S; Weiderpass E; Tjønneland A; Olsen A; Martínez B; Redondo-Sanchez D; Chirlaque MD; Hm Peeters P; Regnér S; Lindkvist B; Naccarati A; Ardanaz E; Larrañaga N; Boutron-Ruault MC; Rebours V; Barré A; Bueno-de-Mesquita HB; Ye W
Int J Cancer; 2017 Apr; 140(8):1727-1735. PubMed ID: 28032715
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori Treatment and Gastric Cancer Risk Among Individuals With High Genetic Risk for Gastric Cancer.
Xu HM; Han Y; Liu ZC; Yin ZY; Wang MY; Yu C; Ma JL; Sun D; Liu WD; Zhang Y; Zhou T; Zhang JY; Pei P; Yang L; Millwood IY; Walters RG; Chen Y; Du H; Chen Z; You WC; Li L; Pan KF; Lv J; Li WQ
JAMA Netw Open; 2024 May; 7(5):e2413708. PubMed ID: 38809553
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection and risk of gastric cancer in Shanghai, China: updated results based upon a locally developed and validated assay and further follow-up of the cohort.
Yuan JM; Yu MC; Xu WW; Cockburn M; Gao YT; Ross RK
Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):621-4. PubMed ID: 10428200
[TBL] [Abstract][Full Text] [Related]
8. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan.
Lin JT; Wang LY; Wang JT; Wang TH; Yang CS; Chen CJ
Anticancer Res; 1995; 15(2):603-6. PubMed ID: 7763044
[TBL] [Abstract][Full Text] [Related]
9. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer.
Aromaa A; Kosunen TU; Knekt P; Maatela J; Teppo L; Heinonen OP; Härkönen M; Hakama MK
Am J Epidemiol; 1996 Jul; 144(2):142-9. PubMed ID: 8678045
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.
Epplein M; Zheng W; Xiang YB; Peek RM; Li H; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Shu XO
Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2185-92. PubMed ID: 23035179
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori seropositivity and risk of lung cancer.
Koshiol J; Flores R; Lam TK; Taylor PR; Weinstein SJ; Virtamo J; Albanes D; Perez-Perez G; Caporaso NE; Blaser MJ
PLoS One; 2012; 7(2):e32106. PubMed ID: 22384154
[TBL] [Abstract][Full Text] [Related]
12. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
13. Seropositivity to Helicobacter pylori and risk of pancreatic cancer.
Yu G; Murphy G; Michel A; Weinstein SJ; Männistö S; Albanes D; Pawlita M; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2416-9. PubMed ID: 24089457
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts.
Lee AA; Wang QL; Kim J; Babic A; Zhang X; Perez K; Ng K; Nowak J; Rifai N; Sesso HD; Buring JE; Anderson GL; Wactawski-Wende J; Wallace R; Manson JE; Giovannucci EL; Stampfer MJ; Kraft P; Fuchs CS; Yuan C; Wolpin BM
Clin Transl Gastroenterol; 2023 May; 14(5):e00573. PubMed ID: 36854058
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors.
Lorenzo I; Fernández-de-Larrea N; Michel A; Romero B; Lope V; Bessa X; Moreno V; Martín V; Amiano P; Castilla J; Tardón A; Dierssen-Sotos T; Peiró R; Díaz-Santos M; Navarro C; Jiménez-Moleón JJ; Butt J; Barricarte A; Ruiz I; Molina-de-la-Torre AJ; Casabonne D; Pérez-Gómez B; Kogevinas M; Del Campo R; de Sanjosé S; Pollán M; Waterboer T; Aragonés N
Eur J Cancer Prev; 2019 Jul; 28(4):294-303. PubMed ID: 30489354
[TBL] [Abstract][Full Text] [Related]
16. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS
Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850
[TBL] [Abstract][Full Text] [Related]
17. Role of anti-parietal cell antibody in Helicobacter pylori-associated atrophic gastritis: evaluation in a country of high prevalence of atrophic gastritis.
Ito M; Haruma K; Kaya S; Kamada T; Kim S; Sasaki A; Sumii M; Tanaka S; Yoshihara M; Chayama K
Scand J Gastroenterol; 2002 Mar; 37(3):287-93. PubMed ID: 11916190
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
[TBL] [Abstract][Full Text] [Related]
20.
Song L; Song M; Rabkin CS; Williams S; Chung Y; Van Duine J; Liao LM; Karthikeyan K; Gao W; Park JG; Tang Y; Lissowska J; Qiu J; LaBaer J; Camargo MC
J Proteome Res; 2021 Jan; 20(1):409-419. PubMed ID: 33108201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
